Synthetic Genomics Inc. (SGI) is a global leader in the fields of synthetic biology and synthetic genomics utilizing their foundational intellectual property in these rapidly evolving disciplines to design and build biological systems to solve global sustainability challenges.

SGI provides solutions in genomics research, bioproduction, and applied products. Their research segment is focused on genomics solutions for academic and commercial R&D organizations. The commercial products and services include instrumentation, reagents, DNA synthesis services, and bioinformatics services and software.

SGI’s efforts in bio-based production are targeted at improving existing biological production hosts and developing entirely new synthetic production hosts with the goal of more efficient production of pharmaceuticals, vaccines, nutritionals, and bio-industrial products derived from renewable biological resources. Their host systems can also enable entirely new products that were once not scientifically or economically viable.